Path

Filing Period

Jan 1, 2010 to Dec 31, 2010

Signed

Oct 13, 2011

Return Version

2010v3.4

Gross Receipts

$292,589,308

Mission

Major Activities

Activity 2

Emerging and epidemic diseases:the burden of emerging and epidemic diseases, including malaria, tuberculosis (tb), hiv/aids, and influenza, falls most heavily on developing countries with the fewest resources to respond. Path works around the globe to help countries respond to these threats by strengthening prevention, diagnosis, and treatment, encouraging healthy behaviors, and mobilizing resources to control disease. In 2010, path worked to enhance hiv education and prevention for at-risk groups, prevent mother-to-child hiv transmission, strengthen care and treatment, and integrate related services. In uganda, a new program aims to prevent hiv infections by addressing the unmet need for contraception among hiv-positive women. In kenya's western province, we led a project that provided hiv testing and counseling to more than 1 million people. The malaria control and evaluation partnership in africa (macepa) worked with global partners to support national efforts in sub-saharan african countries to review malaria programs, implement strategic plans, collect data, and seek new funding for expanded malaria prevention and control. A report co-authored by macepa found the lives of nearly 750,000 children in 34 african countries have been saved by increasing coverage of malaria prevention tools in the past ten years. We addressed the urgent need for tb control by providing extensive technical assistance and support. During epidemics of h1n1 influenza and dengue fever in nicaragua, we helped workers use text messaging to send real-time disease surveillance information to the central health system in managua.

Activity 3

Health technologies:path develops appropriately designed, affordable, and innovative technologies and works to bring them to low-resource settings. Our interventions help improve immunization, nutrition, diagnosis, child survival, and maternal and reproductive health in developing countries.in 2010, our largest technology projects included the safe water project, which is developing and pilot-testing a variety of methods for the commercial production, marketing, and distribution of household water treatment and safe storage solutions in asia and africa. For example, the project completed design of an updated water filter to be distributed in the cambodian marketplace.our jet injector project, which focuses on needle-free syringes for administering vaccines, worked with manufacturers and who to secure regulatory approvals and evaluate the applicability of the technology with different vaccines. And our technologies for health project focused on adapting, designing, developing, and advancing technology solutions for health interventions such as an injectable contraceptive, a product for cleaning umbilical cords, and oxytocin for reducing deaths from postpartum hemorrhage.

Filer

EIN

91-1157127